drugset / Trial / NCT01878825
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the immunogenicity, reactogenicity and safety of Fluviral™ containing the influenza strains recommended for the 2013-2014 season in adults aged 18 years and older.
Timeline
- Start
- 2013-07-18
- Primary completion
- 2013-08-09
- Completion
- 2013-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluviral | Vaccine | — | Intramuscular |